Efficacy and safety of intensified induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed multiple myeloma: a phase2 study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Lenalidomide (Primary) ; Bortezomib; Cyclophosphamide; Dexamethasone; Melphalan
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms JSCT-MM14
- 26 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 03 Aug 2015 Planned initiation date changed from 1 Jul 2015 to 28 Jul 2015 as reported by University Hospital Medical Information Network - Japan.
- 15 Jul 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.